Skip to main content
. 2022 May 15;14(5):3494–3515.

Table 5.

Main cause of deaths for patients with metastatic bladder cancer

Causes of deaths Total <6 months 6 m-1 year 1-3 years 3-5 years >5 years






Observed Expected SMR (95% CI) Observed Expected SMR (95% CI) Observed Expected SMR (95% CI) Observed Expected SMR (95% CI) Observed Expected SMR (95% CI) Observed Expected SMR (95% CI)
All Causes of Death 4,392 161.9 27.13# (26.33-27.94) 1,825 38.29 47.67# (45.51-49.91) 1,193 31.64 37.71# (35.6-39.91) 1,159 47.05 24.63# (23.24-26.09) 153 19.96 7.67# (6.5-8.98) 62 24.97 2.48# (1.9-3.18)
All Malignant Cancers 4,034 37.31 108.13# (104.82-111.52) 1,679 8.94 187.84# (178.96-197.04) 1,112 7.6 146.31# (137.84-155.17) 1,078 11.18 96.42# (90.75-102.35) 127 4.33 29.33# (24.45-34.89) 38 5.26 7.23# (5.11-9.92)
    Urinary Bladder 3,486 1.35 2,575.46# (2490.67-2662.41) 1,431 0.32 4,509.14# (4278.51-4748.97) 983 0.27 3,690.19# (3463.08-3928.29) 948 0.39 2,410.45# (2259.43-2568.91) 103 0.16 638.02# (520.77-773.78) 21 0.22 97.64# (60.44-149.25)
    Prostate 57 3.28 17.38# (13.17-22.52) 23 0.81 28.40# (18-42.61) 11 0.66 16.78# (8.38-30.03) 18 0.93 19.40# (11.5-30.66) 5 0.38 13.27# (4.31-30.96) 0 0.51 0 (0-7.25)
    Lung and Bronchus 54 10.44 5.17# (3.89-6.75) 26 2.54 10.24# (6.69-15) 13 2.18 5.97# (3.18-10.21) 11 3.17 3.47# (1.73-6.21) 2 1.18 1.7 (0.21-6.15) 2 1.38 1.45 (0.18-5.24)
    Kidney and Renal Pelvis 30 0.94 31.93# (21.54-45.58) 19 0.22 85.94# (51.74-134.2) 6 0.19 31.35# (11.51-68.24) 3 0.28 10.59# (2.18-30.95) 0 0.11 0 (0-33.63) 2 0.13 14.91# (1.81-53.87)
    Colon and Rectum 20 3.29 6.08# (3.72-9.39) 8 0.8 9.98# (4.31-19.66) 2 0.67 2.98 (0.36-10.77) 7 0.98 7.15# (2.87-14.72) 0 0.38 0 (0-9.66) 3 0.45 6.61# (1.36-19.32)
    Liver 11 1.13 9.70# (4.84-17.35) 7 0.25 27.85# (11.2-57.38) 2 0.22 8.89# (1.08-32.13) 2 0.34 5.81 (0.7-21) 0 0.14 0 (0-26.41) 0 0.17 0 (0-21.14)
    Ureter 10 0.03 328.79# (157.67-604.65) 5 0.01 710.34# (230.64-1657.69) 3 0.01 504.18# (103.97-1473.41) 1 0.01 111.49# (2.82-621.17) 1 0 270.84# (6.86-1509.04) 0 0 0 (0-774.36)
Non-tumor diseases
    Diseases of Heart 128 43.28 2.96# (2.47-3.52) 59 10.4 5.67# (4.32-7.32) 23 8.44 2.73# (1.73-4.09) 30 12.42 2.42# (1.63-3.45) 8 5.32 1.5 (0.65-2.96) 8 6.69 1.2 (0.52-2.36)
    Chronic Obstructive Pulmonary Disease and Allied Cond 30 10.28 2.92# (1.97-4.17) 9 2.42 3.72# (1.7-7.06) 8 2.03 3.95# (1.7-7.77) 8 3.03 2.64# (1.14-5.21) 3 1.25 2.41 (0.5-7.03) 2 1.56 1.28 (0.16-4.64)
    Septicemia 26 2.34 11.11# (7.26-16.28) 10 0.56 17.93# (8.6-32.97) 6 0.46 13.04# (4.79-28.39) 6 0.68 8.78# (3.22-19.1) 2 0.28 7.09 (0.86-25.6) 2 0.36 5.61 (0.68-20.25)
    Cerebrovascular Diseases 23 8.97 2.56# (1.63-3.85) 8 2.15 3.71# (1.6-7.32) 7 1.72 4.07# (1.63-8.38) 5 2.56 1.95 (0.63-4.55) 2 1.13 1.76 (0.21-6.37) 1 1.4 0.72 (0.02-3.98)
    Other Infectious and Parasitic Diseases including HIV 15 1.35 11.15# (6.24-18.38) 5 0.32 15.77# (5.12-36.8) 5 0.27 18.31# (5.94-42.73) 2 0.4 4.98 (0.6-18) 1 0.16 6.2 (0.16-34.56) 2 0.19 10.36# (1.25-37.42)
    Symptoms, Signs and Ill-Defined Conditions 12 1.85 6.48# (3.35-11.33) 9 0.44 20.49# (9.37-38.89) 1 0.35 2.83 (0.07-15.77) 2 0.53 3.8 (0.46-13.73) 0 0.24 0 (0-15.55) 0 0.29 0 (0-12.53)

Abbreviations: SMR, standardized mortality ratio; CI, confidence interval;

#

significant difference.